Peterson LC - Search Results

1

Treatment of hairy-cell leukemia: current views.

Tallman MS, Peterson LC, Hakimian D, Gillis S, Polliack A. Tallman MS, et al. Among authors: peterson lc. Semin Hematol. 1999 Apr;36(2):155-63. Semin Hematol. 1999. PMID: 10319384 Review.

2

Immunophenotypic variations in hairy cell leukemia.

Chen YH, Tallman MS, Goolsby C, Peterson L. Chen YH, et al. Am J Clin Pathol. 2006 Feb;125(2):251-9. doi: 10.1309/PMQX-VY61-9Q8Y-43AR. Am J Clin Pathol. 2006. PMID: 16393677

3

Splenectomy and treatments of historical interest.

Zakarija A, Peterson LC, Tallman MS. Zakarija A, et al. Among authors: peterson lc. Best Pract Res Clin Haematol. 2003 Mar;16(1):57-68. doi: 10.1016/s1521-6926(02)00083-x. Best Pract Res Clin Haematol. 2003. PMID: 12670465 Review.

4

Treatment of hairy cell leukemia with 2-chlorodeoxyadenosine (2-CdA): long-term follow-up of the Northwestern University experience.

Chadha P, Rademaker AW, Mendiratta P, Kim B, Evanchuk DM, Hakimian D, Peterson LC, Tallman MS. Chadha P, et al. Among authors: peterson lc. Blood. 2005 Jul 1;106(1):241-6. doi: 10.1182/blood-2005-01-0173. Epub 2005 Mar 10. Blood. 2005. PMID: 15761021 Free article. Clinical Trial.

5

Assessment of complete remission after 2-chlorodeoxyadenosine for hairy cell leukemia: utility of marrow immunostaining and measurement of splenic index.

Tallman MS, Hakimian D, Dyrda S, Kiley C, Nemcek A, Peterson L. Tallman MS, et al. Leuk Lymphoma. 1994;14 Suppl 1:133-8. Leuk Lymphoma. 1994. PMID: 7529609 Clinical Trial.

6

Detection of minimal residual disease by immunostaining of bone marrow biopsies after 2-chlorodeoxyadenosine for hairy cell leukemia.

Hakimian D, Tallman MS, Kiley C, Peterson L. Hakimian D, et al. Blood. 1993 Sep 15;82(6):1798-802. Blood. 1993. PMID: 7691237 Free article.

7

Minimal residual disease may predict bone marrow relapse in patients with hairy cell leukemia treated with 2-chlorodeoxyadenosine.

Wheaton S, Tallman MS, Hakimian D, Peterson L. Wheaton S, et al. Blood. 1996 Feb 15;87(4):1556-60. Blood. 1996. PMID: 8608247 Free article.

8

Massive splenomegaly in hairy cell leukemia.

Tallman MS, Hakimian D, Peterson L. Tallman MS, et al. J Clin Oncol. 1998 Mar;16(3):1232-3. doi: 10.1200/JCO.1998.16.3.1232. J Clin Oncol. 1998. PMID: 9508212 No abstract available.

9

Relapse of hairy cell leukemia after 2-chlorodeoxyadenosine: long-term follow-up of the Northwestern University experience.

Tallman MS, Hakimian D, Rademaker AW, Zanzig C, Wollins E, Rose E, Peterson LC. Tallman MS, et al. Among authors: peterson lc. Blood. 1996 Sep 15;88(6):1954-9. Blood. 1996. PMID: 8822913 Free article. Clinical Trial.

10

Minimal residual disease in patients with hairy cell leukemia in complete remission treated with 2-chlorodeoxyadenosine or 2-deoxycoformycin and prediction of early relapse.

Tallman MS, Hakimian D, Kopecky KJ, Wheaton S, Wollins E, Foucar K, Cassileth PA, Habermann T, Grever M, Rowe JM, Peterson LC. Tallman MS, et al. Among authors: peterson lc. Clin Cancer Res. 1999 Jul;5(7):1665-70. Clin Cancer Res. 1999. PMID: 10430066

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

135 results

Search Page

Filters